Rodin Therapeutics

Rodin Therapeutics is a biotechnology company focused on treating neurological disorders and is currently developing innovative drugs. By applying novel chemical strategies, Rodin Therapeutics designs molecules capable of safely upregulating genes crucial to learning and memory, aiming to discover and develop first-in-class therapies for synaptopathies. Backed by an enhanced synaptic strategy, Rodin Therapeutics' targeted approach to strengthening synaptic integrity holds potential across multiple synaptopathies, including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, schizophrenia, and major depressive disorder, all of which are characterized by impaired neuronal and synaptic function. The vision of Rodin Therapeutics is to significantly and sustainably improve the quality of life for patients and their caregivers.